Tectonic Therapeutic | AVRO - Market Capitalization


Tectonic Therapeutic reported $431.6M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Cspc Pharmaceutical CNY 99.86B 3.93B Aug/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 2.21T 464.84B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
MacroGenics USD 184M 82M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 37.11M 25.41M Aug/2026
Neuren Pharmaceuticals AUD 2.44B 80.57M Aug/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 5.1M 3.93M Aug/2026
Pfizer USD 143.89B 5.44B Aug/2026
Pharma Mar EUR 1.39B 78.26M Aug/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Takeda JPY 8.2T 809.7B Jun/2026
Zealand Pharma A/S 33.35B 12.51B Aug/2026